U.S. Physical Therapy, Inc. (USPH)

NYSE: USPH · USD

$86.5

-0.84 (-1.0%)· Recorded snapshot

Market cap	1.3B
Revenue (ttm)	804.3M
Net income (ttm)	2.7M
EPS (ttm)	$0.18
Shares out	14.9M
P/E (trailing)	492.7x
P/E (forward)	28.5x
Dividend	$1.84 (2.14%)
Volume	159,487
Beta	1.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 804.3M
Net income (ttm): 2.7M
EPS (ttm): $0.18
P/E (trailing): 492.7x
P/E (forward): 28.5x
Market cap: 1.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E28.5

P25 n/aP50 n/aP75 n/a

Trailing P/E492.7

P25 n/aP50 n/aP75 n/a

ROE6.5

P25 n/aP50 n/aP75 n/a

ROIC5.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All USPH indicators

Market & fundamental data

Available fields

286

Groups with data

Currency

USD

Showing 286 of 286 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000885978
Company name	U.S. Physical Therapy, Inc.
Country	United States
Country code	US
CUSIP number	90337L108
Earnings date	2026-11-04
Earnings time	amc
Employees	8,095
Employees change	1,067
Employees growth	15.18%
Enterprise value	$1.7B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1990
In index	RUSSELL2000
Industry	Medical Care Facilities
IPO date	1992-05-28
Is primary listing	Yes
Is SPAC	No
ISIN number	US90337L1089
Last 10-K release date	2026-02-27
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2001-06-29
Last stock split type	Forward
Market cap	$1.3B
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$86.50
Price currency	USD
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-28
Symbol	USPH
U.S. state	Texas
Website	https://www.usph.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	34.06x
Average P/E ratio (10Y)	62.11x
Average P/E ratio (3Y)	96.46x
Average P/E ratio (5Y)	74.65x
Earnings yield	0.2%
EV/Earnings	621.49x
EV/EBIT	20.77x
EV/EBITDA	16.21x
EV/FCF	25.8x
EV/Sales	2.06x
FCF / EV yield	3.88%
FCF yield	4.95%
Forward EV/Sales	1.88x
Forward P/E	28.49x
Forward P/S	1.47x
Graham number	10.8974
Graham upside	-87.43%
Industry forward P/E	14.81x
Industry P/E	18.21x
Lynch fair value	$0.88
Lynch upside	-98.99%
P/(FCF - SBC) ratio	23.86x
P/(OCF - SBC) ratio	17.68x
P/B ratio	2.91x
P/E ratio	492.71x
P/FCF ratio	20.19x
P/OCF ratio	15.58x
P/S ratio	1.61x
PEG ratio	2.4x
Price/EBITDA ratio	12.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.9%
EBITDA margin	12.68%
Effective tax rate	26.06%
FCF margin	7.97%
Gross margin	21.47%
Operating margin	9.9%
Pretax margin	8.39%
Profit margin	4.01%
Profit per employee	$329
Profitable quarters	125
Profitable years	31
Revenue per employee	$99,354
ROA	4.1%
ROA (5Y)	4.94%
ROCE	6.99%
ROE	6.51%
ROE (5Y)	8.66%
ROIC	5.25%
ROIC (5Y)	7.2%
SBC / revenue	1.23%
Tax / revenue	2.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-92.32%
EPS growth (Q)	-56.46%
EPS growth 10Y	-20.22%
EPS growth 3Y	-55.03%
EPS growth 5Y	-40.3%
EPS growth years	0
FCF growth	5.26%
FCF growth (Q)	-8.24%
FCF growth 3Y	1.32%
FCF growth 5Y	-4.55%
Gross profit growth	8.4%
Gross profit growth (Q)	0.29%
Gross profit growth 3Y	13.63%
Gross profit growth 5Y	7.59%
Net income growth	-15.56%
Net income growth (Q)	-20.13%
Net income growth 3Y	-52.93%
Net income growth 5Y	-38.32%
Net income growth years	2
OCF growth	15.81%
OCF growth (Q)	-1.41%
OCF growth (QoQ)	802.57%
OCF growth 10Y	5.35%
OCF growth 3Y	5.96%
OCF growth 5Y	-0.97%
Operating income growth	5.7%
Operating income growth (Q)	-3.96%
Operating income growth 3Y	5.47%
Operating income growth 5Y	1.07%
Revenue growth	11.36%
Revenue growth (Q)	8.49%
Revenue growth (QoQ)	7.98%
Revenue growth 10Y	8.87%
Revenue growth 3Y	11.83%
Revenue growth 5Y	11.79%
Revenue growth quarters	21
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-19M
Depreciation and amortization	$22.4M
EBIT	$79.6M
EBITDA	$102M
EPS	$0.18
FCF per share	$4.29
Financing cash flow	$-28.7M
Free cash flow	$64.1M
Free cash flow minus SBC	$54.2M
Gross profit	$172.7M
Income taxes	$17.6M
Investing cash flow	$-63.6M
Net borrowing	$60.4M
Net cash flow	$-9.2M
Net income	$2.7M
Operating cash flow minus SBC	$73.2M
Operating income	$79.6M
Revenue	$804.3M
Stock-based compensation	$9.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.59
Book value per share	$30.06
Debt / EBITDA	2.34
Debt / equity	0.5
Debt / FCF	6.02
Goodwill	$716.5M
Interest coverage	7.4
Long-term assets	$1.1B
Long-term liabilities	$372.3M
Net cash (debt)	$-359.5M
Net cash / market cap	-27.79%
Net debt / EBITDA	3.52
Net debt / equity	0.47
Net debt / FCF	5.61
Piotroski F-Score	6
Property, plant and equipment	$196.9M
Shareholders' equity	$766.7M
Tangible book value	$-444.4M
Tangible book value per share	$-29.78
Total assets	$1.2B
Total cash	$26.3M
Total debt	$385.8M
Total liabilities	$482.2M
WACC	8.47%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.66
Current assets	$139.7M
Current liabilities	$109.9M
Current ratio	1.27
Net working capital	$50.9M
Quick ratio	1.13
Working capital	$29.8M
Working capital turnover	31.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.18%
Dividend growth	2.23%
Dividend growth (10Y)	10.74%
Dividend growth (3Y)	2.49%
Dividend growth (5Y)	11.12%
Dividend growth years	5
Dividend payment date	2026-09-11
Dividend payment years	16
Dividend payout frequency	Quarterly
Dividend per share	$1.84
Dividend yield	2.14%
Ex-dividend date	2026-08-21
FCF payout ratio	42.85%
Last dividend	$0.46
Payout ratio	1,048.07%
Shareholder yield	1.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	46.76%
10Y return CAGR	5.46%
10Y total return	70.09%
150-day SMA	$74.82
15Y price change	312.05%
15Y return CAGR	11.61%
15Y total return	419.65%
1D price change	-0.96%
1M price change	0.78%
1M total return	0.78%
1W price change	-1.75%
1W total return	-1.75%
1Y price change	-6.04%
1Y return CAGR	-3.62%
1Y total return	-3.62%
20-day SMA	$85.45
200-day SMA	$76.74
20Y price change	601.97%
20Y return CAGR	11.58%
20Y total return	795.27%
3M price change	11.56%
3M total return	12.22%
3Y price change	1.18%
3Y return CAGR	2.63%
3Y total return	8.11%
50-day SMA	$82.52
50-day SMA vs 200-day SMA	50over200
52-week high	$93.26
52-week high date	2025-10-29
52-week low	$58.19
52-week low date	2026-05-08
5Y price change	-16.33%
5Y return CAGR	-1.55%
5Y total return	-7.49%
6M price change	16.82%
6M total return	18.38%
All-time high	$148.48
All-time high date	2019-11-05
All-time low	$1.42
All-time low date	1992-10-07
Average true range (ATR)	$2.75
Average volume	160.6K
Beta (1Y)	0.25
Beta (2Y)	1.04
Beta (5Y)	1.11
Change from 52-week high	-7.25%
Change from 52-week low	48.65%
Change from all-time high	-42.42%
Change from all-time low	5,933.87%
Change from open	-1.14%
Day's gap	0.18%
Dollar volume	$13.8M
High price	$88.25
Low price	$86.50
Monthly RSI	52.63
Open price	$87.50
Position in 52-week range	0%
Premarket change	0.3%
Premarket close	$87.34
Premarket price	$87.60
Premarket volume	2.4K
Previous close	$87.34
Price vs 150-day SMA	14.27%
Price vs 20-day SMA	0.06%
Price vs 200-day SMA	11.41%
Price vs 50-day SMA	3.61%
Relative volume	0.99
RSI	51.58
Sharpe ratio	0
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	0
Sortino ratio	0.13
Sortino ratio (3Y)	0.33
Sortino ratio (5Y)	0.15
Volume	159.5K
Weekly RSI	60.66
YTD price change	9.49%
YTD total return	11.61%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14.5M
Float percentage	97.41%
Shares change (QoQ)	-0.64%
Shares change (YoY)	0.18%
Shares held by insiders	2.57%
Shares held by institutions	110.67%
Shares outstanding	14.9M
Short % of float	8.95%
Short % of shares	8.71%
Short ratio	7.4 days

Deeper analysis on USPH

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this USPH report

Is a complete USPH research report available?

No complete published report is available for U.S. Physical Therapy, Inc. (USPH) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

U.S. Physical Therapy, Inc. (USPH)

Price

Financial snapshot

Fair-value bridge

Latest news · USPH

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All USPH indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on USPH

Frequently asked questions